Profile for Ligand Pharmaceuticals Incorporated (LGND)

$ 117.66   2.21 (+1.91%) Volume: 169.42k 4:00 PM EDT 7-Aug-2020
After Hours:  $ 117.66 0.00 (0.00%) Volume: 5.02k 4:45 PM EDT 7-Aug-2020
Business Description:
Ligand Pharmaceuticals Inc is a biopharmaceutical company. Its business model is based upon the concept of acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure.
Address: 3911 Sorrento Valley Boulevard, Suite 110, San Diego, CA, USA, 92121
Telephone: +1 858 550-7500 Website:
Facsimile: N/A Email: [email protected]
CEO: John L. Higgins
Employees: 115 Market Cap: 1.89b
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 886163
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)